DOI: http://dx.doi.org/10.18203/2349-3933.ijam20213251

Acute ischemic stroke in COVID-19: a case report

Mamatha Tittamegalapalya Ramalingaiah, Jeetendra Kumar Jogihalli Mood, Vinutha Bagalur Srinivas Murthy, Virender Singh

Abstract


Corona virus disease (COVID-19) is an infectious disease caused by SARS-CoV-2 virus. It predominantly affects respiratory system causing fever, cough, and breathlessness. But it can also affect central nervous system. Clinicians must adopt methodical approach in investigating a patient with neurological manifestation. Early detection and treatment is required for neurological disease of COVID-19 to reduce post COVID neurological sequel.

 


Keywords


Stroke, COVID-19, D-dimer, CRP

Full Text:

PDF

References


Mao L, Jin H, Wang M, Hu Y, Chen S, He Q. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol. 2020;45(35):25-9.

Qureshi AI, Abd-Allah F, Alsenani F, Aytac E, Borhani-Haghighi A, Ciccone A, et al. Management of acute ischemic stroke in patients with COVID-19 infection: Report of an international panel. Int J Stroke. 2020;2020;174.

Yaghi S, Ishida K, Torres J, Mac Grory B, Raz E, Humbert K, et al. SARS2-CoV-2 and stroke in a New York healthcare system. Stroke. 2020;50(6);2120-8.

Qin C, Zhou L, Hu Z, Yang S, Zhang S, Chen M, et al. Clinical characteristics and outcomes of COVID-19 patients with a history of stroke in Wuhan, China. Stroke. 2020;51(7):2219-23.

Wijeratne T, Sales C, Karimi L, Crewther SG. Acute ischemic stroke in COVID-19: a case-based systematic review. Front Neurol. 2020;11:1031.

Mohamed IZB, Balson L, Madathil S. Massive bilateral stroke in a COVID-19 patient. BMJ Case Rep. 2020;13:e236-54.

Sriwastava S, Srivastava S, Kataria S, Melnic V, Adcock A, Sheikh Z. Neurological complications of COVID-19: a systematic review of literature. Front Neurol. 2020;10:212-6.

Nassir CMN, Hashim S, Wong KK, Abdul Halim S, Idris NS, Jayabalan N, et al. COVID-19 infection and circulating microparticles-reviewing evidence as microthrombogenic risk factor for cerebral small vessel disease. Mol Neurobiol. 2021;26:1-28.

D’Anna L, Kwan J, Brown Z. Characteristics and clinical course of Covid-19 patients admitted with acute stroke. J Neurol. 2020;10:1007-12.

Madjid M, Safavi-Naeini P, Solomon SD, Vardeny O. Potential effects of coronaviruses on the cardiovascular system: a review. JAMA Cardiol. 2020;45:52-9.

Zurrú MC, Alonzo C, Brescacín L. Recent respiratory infection predicts atherothrombotic stroke: case-control study in a Buenos Aires healthcare system. Stroke. 2009;40:1986-90.

Cowan LT, Lutsey PL, Pankow JS. Inpatient and outpatient infection as a trigger of cardiovascular disease: the ARIC study. J Am Heart Assoc. 2018;7: e9683-9.

Grau AJ, Buggle F, Becher H. Recent bacterial and viral infection is a risk factor for cerebrovascular ischemia: clinical and biochemical studies. Neurol. 1998;50:196-203.

Bova IY, Bornstein NM, Korczyn AD. Acute infection as a risk factor for ischemic stroke. Stroke. 1996;27:2204-6.

Lindsberg PJ, Grau AJ. Inflammation and infections as risk factors for ischemic stroke. Stroke. 2003;34: 2518-32.

Becher H, Grau A, Steindorf K. Previous infection and other risk factors for acute cerebrovascular ischaemia: attributable risks and the characterisation of high-risk groups. J Epidemiol Biostat. 2000;5:277-83.

Escalard S, Maïer B, Redjem H, Delvoye F, Hébert S, Smajda S, et al. Treatment of acute ischemic stroke due to large vessel occlusion with COVID-19: experience from Paris. Stroke. 2020;29:120-9.

Oxley TJ, Mocco J, Majidi S, Kellner CP, Shoirah H, Singh IP, et al. Large-vessel stroke as a presenting feature of Covid-19 in the young. N Engl J Med. 2020;382:e60.